埃索美拉唑吃多久停药

Esomeprazole is mainly used for:

1. Gastroesophageal reflux disease (GERD);

2. Treatment of erosive reflux esophagitis;

3. Long-term maintenance treatment to prevent recurrence of cured esophagitis patients.

So, how long does it take for patients to stop taking esomeprazole?

Esomeprazole can be taken for a long time, but when any alarm symptoms occur (such as significant unintentional weight loss, repeated vomiting, difficulty swallowing, vomiting blood or melena), when gastric ulcer is suspected or gastric ulcer is already present, malignant tumors should be ruled out, because treatment with esomeprazole dissolvable tablets can reduce symptoms and delay diagnosis. Patients treated with this drug for a long period of time (especially those using it for more than 1 year) should be monitored regularly.

Patients should have a comprehensive understanding of their physical conditions and use medications correctly under the guidance of relevant doctors or pharmacists to ensure their own health. Generally speaking, chronic diseases or diseases that require medication for a relatively long period of time need to be treated according to the course of treatment, which means that a disease is treated and observed in stages. After a course of treatment, the medicine is adjusted according to the situation (because the effect of chronic diseases will not be seen in one or two days). However, this does not mean that you should stop taking it after a course of treatment. You must stop taking the medicine according to the condition of the disease.

Esomeprazole is a proton pump inhibitor and is often used in combination with antibiotics to form triple or quadruple therapy to treat gastrointestinal ulcers. Esomeprazole is a film-coated tablet.

Esomeprazole reduces gastric acid secretion through a specific targeting mechanism and is a specific inhibitor of proton pumps in parietal cells. The R-isomer and S-isomer of esomeprazole have similar pharmacodynamic properties.

Esomeprazole is a weak base, which is concentrated in the high-acid environment of the acid secretion microtubules of parietal cells and converted into an active form, thereby inhibiting the H+/K+-ATPase (proton pump) at this site, inhibiting both basic gastric acid secretion and stimulated gastric acid secretion. Esomeprazole should be taken and discontinued correctly according to the condition and under the guidance of a professional doctor to ensure medication safety.